CloudScreen is a next generation “one-stop-shop” platform for drug repositioning and repurposing. 1D and 3D data are integrated to reveal the drugable proteome and variome (proteoforms). Efficacy and toxicity predictions are the net outcome of AI and human synergies.

This research is supported by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH—CREATE—INNOVATE (project code: T2EDK-03153)